Matinas BioPharma Holdings (MTNB) EPS (Basic) (2014 - 2026)
Matinas BioPharma Holdings (MTNB) posted quarterly EPS (Basic) of -$0.3 for Q1 2026, up 7.89% year-over-year from -$0.28 in Q1 2025, and up 68.7% quarter-over-quarter from -$0.96 in Q4 2025.
Matinas BioPharma Holdings (MTNB) EPS (Basic) (2014 - 2026) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has reported EPS (Basic) for 13 consecutive years, with -$0.3 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 7.89% year-over-year to -$0.3; the TTM figure through Mar 2026 stood at -$1.78 (up 62.33% YoY), while the FY2025 annual figure was -$2.0, up 59.82% from the prior year.
- EPS (Basic) improved to -$0.3 in Q1 2026 per MTNB's latest filing, from -$0.96 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.3 in Q1 2026 and bottomed at -$1.95 in Q2 2024.
- Historically, EPS (Basic) has averaged -$1.15 across 5 years, with a median of -$1.36 in 2023.
- Annual changes were most pronounced in 2023 — EPS (Basic) sank 61.66% — and 2025, when it surged 79.33%.
- Matinas BioPharma Holdings' EPS (Basic) stood at -$0.84 in 2022, then slumped by 61.66% to -$1.36 in 2023, then decreased by 27.9% to -$1.73 in 2024, then surged by 44.72% to -$0.96 in 2025, then jumped by 68.7% to -$0.3 in 2026.
- Business Quant data shows MTNB's EPS (Basic) at -$0.3 in Q1 2026, -$0.96 in Q4 2025, and -$0.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.53 Bn | 130.68 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.34 Bn | 78.35 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.67 Bn | 59.48 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.03 Bn | 36.94 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.78 Bn | 27.47 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 27.81 Bn | 9.42 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.21 Bn | 26.05 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 26.99 Bn | 26.15 Bn | - | 0.18 |
| 10 | Matinas BioPharma Holdings | 1.18 Mn | 373,504.72 | - | -0.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.21 |
| Mar 31, 2026 | -0.30 |
| Dec 31, 2025 | -0.96 |
| Sep 30, 2025 | -0.40 |
| Jun 30, 2025 | -0.41 |
| Mar 31, 2025 | -0.33 |
| Dec 31, 2024 | -1.73 |
| Sep 30, 2024 | -0.85 |
| Jun 30, 2024 | -1.95 |
| Mar 31, 2024 | -1.57 |
| Dec 31, 2023 | -1.36 |
| Sep 30, 2023 | -1.65 |
| Jun 30, 2023 | -1.66 |
| Mar 31, 2023 | -1.53 |
| Dec 31, 2022 | -0.84 |
| Sep 30, 2022 | -1.26 |
| Jun 30, 2022 | -1.37 |
| Mar 31, 2022 | -1.38 |
| Dec 31, 2021 | -1.59 |
| Sep 30, 2021 | -1.59 |